# OnCo record paper-rosenwald-molecular-profiling-dlbcl-nejm-2002 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-rosenwald-molecular-profiling-dlbcl-nejm-2002/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-rosenwald-molecular-profiling-dlbcl-nejm-2002" ;
  schema:name "The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma"@en ;
  schema:alternateName "Rosenwald 2002"@en, "Lymphoma/Leukemia Molecular Profiling Project 240 biopsies"@en, "Germinal-centre, activated and type 3 diffuse large B-cell lymphoma"@en ;
  schema:description "Reading which genes were switched on in 240 lymphoma samples sorted one disease into three, and the group whose cells looked like a particular stage of normal B-cell development lived the longest."@en ;
  schema:url <https://onco.cc/key-papers/paper-rosenwald-molecular-profiling-dlbcl-nejm-2002/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa012914>, <https://pubmed.ncbi.nlm.nih.gov/12075054/>, <https://europepmc.org/article/MED/12075054> ;
  onco:tag "lymphoma-evidence" ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa012914> ;
  schema:datePublished "2002"^^xsd:gYear ;
  schema:author "Rosenwald A, Wright G, Chan WC, et al." ;
  onco:related <https://onco.cc/key-papers/paper-alizadeh-nature/>, <https://onco.cc/key-papers/paper-hans-immunohistochemistry-cell-of-origin-dlbcl-blood-2004/>, <https://onco.cc/key-papers/paper-schmitz-genetics-pathogenesis-dlbcl-nejm-2018/>, <https://onco.cc/roadmaps/lymphoma-roadmap/> ;
  onco:cancers <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/diagnostics/>, <https://onco.cc/fronts/ai-computation/> ;
  onco:targets <https://onco.cc/targets/bcl2/>, <https://onco.cc/targets/bcl6/>, <https://onco.cc/pathways/myc/> ;
  onco:institutions <https://onco.cc/institutions/nci/> ;
  onco:terms <https://onco.cc/terms/cell-of-origin/>, <https://onco.cc/terms/ipi-score/> ;
  onco:people <https://onco.cc/people/louis-staudt/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-tumor-heterogeneity/>, <https://onco.cc/bottlenecks/b-biomarker-validation/> ;
  onco:journals <https://onco.cc/journals/nejm/> .